Lonafarnib

What Lonafarnib Means in Everyday Medical Language

Lonafarnib is a medicine taken by mouth that blocks an enzyme called farnesyltransferase. This enzyme helps add a small chemical group to certain proteins, which is important for their function. Some of these proteins, like Ras, play roles in cell growth and aging. By blocking this enzyme, lonafarnib can affect how these proteins work.

Lonafarnib is sold under the brand name Zokinvy and is mainly used to treat Hutchinson-Gilford progeria syndrome (HGPS), a very rare genetic disorder where children show signs of aging very early in life. It is also used for certain related conditions called progeroid laminopathies, which have similar genetic causes and symptoms.

Why Lonafarnib Can Matter in Cancer Care and Other Diseases

Originally, lonafarnib was developed to treat cancers driven by abnormal Ras proteins, which are involved in about 30% of human cancers such as pancreatic, colorectal, and lung cancers. It was tested in many clinical trials but did not become a standard cancer treatment because it was not effective enough on its own.

However, lonafarnib’s ability to block farnesyltransferase has proven useful in treating progeria, where it helps reduce harmful buildup of defective proteins that cause early aging symptoms. It has also shown promise in treating hepatitis D virus infections when combined with other medicines like ritonavir.

What Patients Might See or Hear About Lonafarnib

If lonafarnib is mentioned in your medical records, treatment plan, or discussions, it may be called by its other name, SCH 66336. You might hear about it as a treatment for progeria or in clinical trials for hepatitis D or cancer. Common side effects include nausea, vomiting, headache, diarrhea, decreased appetite, and fatigue.

Because lonafarnib affects important proteins in cells, doctors carefully monitor patients for side effects and drug interactions. For example, it should not be taken with certain medicines that affect liver enzymes, as this can change how lonafarnib works in the body.

Where You Might Encounter the Term Lonafarnib

Lonafarnib may appear in your medical records, especially if you or a loved one is being treated for progeria or related conditions. It can also be mentioned in clinical trial information, drug fact sheets, or cancer-related resources. Sometimes it appears alongside other drugs like ritonavir, especially in studies of hepatitis D virus treatment.

What Lonafarnib Does Not Automatically Mean

Seeing lonafarnib mentioned does not mean you have cancer or progeria. It is a medication that may be part of a treatment plan or a research study. It also does not guarantee a cure or full control of a disease. Its use and effects depend on the specific condition and individual patient factors.

Common Questions to Ask Your Care Team

If lonafarnib comes up in your care, you might ask: What is lonafarnib being used for in my or my loved one’s treatment? What benefits and risks should I expect? Are there side effects I should watch for? How does lonafarnib interact with other medicines I am taking? Are there clinical trials involving lonafarnib that might be relevant?

How to Understand Lonafarnib in Context

Lonafarnib is one of many medicines that target enzymes involved in cell function. Knowing its other name, SCH 66336, can help avoid confusion when reading medical reports or research articles. Always consider the full medical context and discuss with your healthcare team what lonafarnib means for your care.

Safety and Next Steps

This information is educational and does not replace medical advice. Only your healthcare provider can decide if lonafarnib is safe or appropriate for you or your loved one. If you see lonafarnib mentioned in your records or hear about it from your care team, the best next step is to ask them directly what it means for your specific situation and treatment plan.